Andere Kunden interessierten sich auch für
![Trends in Contraceptive Use Worldwide 2015]( "Trends in Contraceptive Use Worldwide 2015")
Trends in Contraceptive Use Worldwide 201520,99 €![Contraceptive Use by Method 2019]( "Contraceptive Use by Method 2019")
Contraceptive Use by Method 201924,99 €![A Practical Introduction to Security and Risk Management]( "A Practical Introduction to Security and Risk Management")
A Practical Introduction to Security and Risk Management162,99 €![To Authorize the Secretary of Housing and Urban Development, in Coordination with the Secretary of Veterans Affairs, to Carry Out a Pilot Program to Prevent At-Risk Veterans and Veteran Families from Falling Into Homelessness, and for Other Purposes. - Sch]( "To Authorize the Secretary of Housing and Urban Development, in Coordination with the Secretary of Veterans Affairs, to Carry Out a Pilot Program to Prevent At-Risk Veterans and Veteran Families from Falling Into Homelessness, and for Other Purposes. - Sch")
To Authorize the Secretary of Housing and Urban Development, in Coordination with the Secretary of Veterans Affairs, to Carry Out a Pilot Program to Prevent At-Risk Veterans and Veteran Families from Falling Into Homelessness, and for Other Purposes. - Sch17,99 €![Organizational Characteristics Associated with Risk of Sexual Assault and Sexual Harassment in the U.S. Army]( "Organizational Characteristics Associated with Risk of Sexual Assault and Sexual Harassment in the U.S. Army")
Organizational Characteristics Associated with Risk of Sexual Assault and Sexual Harassment in the U.S. Army40,99 €![Human Rights at Risk]( "Human Rights at Risk")
Human Rights at Risk42,99 €![The Great Risk Shift]( "The Great Risk Shift")
The Great Risk Shift18,99 €
The story of Depo-Provera joins the national struggle over the drug's FDA approval to the state legal issues raised by its contraceptive and criminal justice uses. Depo-Provera is known as an injectable hormonal birth control method, but few are familiar with its dark and complicated history. Depo-Provera was tested on women since the mid-1960s without their informed consent until it was FDA-approved in 1992, but never FDA-approved as chemical castration for male sex offenders. Contraceptive Risk is William Green's landmark study of Depo-Provera. Based on a fascinating combination of archival materials and interviews, the book is framed as three interconnected stories told by Judith Weisz, who chaired the FDA's Public Board of Inquiry on Depo-Provera, a scientific court; by Anne MacMurdo who brought a products liability suit against Upjohn, the drug's manufacturer, for the deleterious side effects she suffered from the drug's use; and by Roger Gauntlett, an Upjohn heir who, when he was convicted of sexual assault, refused to take a dose of his family's own medicine as a probation condition. Together these three stories of Depo-Provera's convoluted fifty year odyssey call for a paradigm shift in pharmaceutical drug development. Contraceptive Risk is a thoroughly researched and engrossing approach to the scientific, political and institutional forces involved in health law and policy, as well as the multifaceted politics of measuring risk.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.